146 related articles for article (PubMed ID: 37500260)
1. Single-Time-Point Imaging for Dosimetry After [
Wang C; Peterson AB; Wong KK; Roseland ME; Schipper MJ; Dewaraja YK
J Nucl Med; 2023 Sep; 64(9):1463-1470. PubMed ID: 37500260
[TBL] [Abstract][Full Text] [Related]
2. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for
Peterson AB; Mirando DM; Dewaraja YK
EJNMMI Res; 2023 Jun; 13(1):57. PubMed ID: 37306783
[TBL] [Abstract][Full Text] [Related]
3. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in clinical patients and realistic simulations.
Peterson AB; Mirando DM; Dewaraja YK
Res Sq; 2023 Apr; ():. PubMed ID: 37131738
[No Abstract] [Full Text] [Related]
4. Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [
Hardiansyah D; Yousefzadeh-Nowshahr E; Kind F; Beer AJ; Ruf J; Glatting G; Mix M
J Nucl Med; 2024 Apr; 65(4):566-572. PubMed ID: 38423787
[TBL] [Abstract][Full Text] [Related]
5. 177Lu-DOTATATE Theranostics: Predicting Renal Dosimetry From Pretherapy 68Ga-DOTATATE PET and Clinical Biomarkers.
Peterson AB; Wang C; Wong KK; Frey KA; Muzik O; Schipper MJ; Dewaraja YK
Clin Nucl Med; 2023 May; 48(5):393-399. PubMed ID: 37010563
[TBL] [Abstract][Full Text] [Related]
6. Impact of Single-Time-Point Estimates of
Chicheportiche A; Sason M; Zidan M; Godefroy J; Krausz Y; Gross DJ; Grozinsky-Glasberg S; Ben-Haim S
J Nucl Med; 2023 Oct; 64(10):1610-1616. PubMed ID: 37500259
[TBL] [Abstract][Full Text] [Related]
7. A Novel Time-Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After
Devasia TP; Dewaraja YK; Frey KA; Wong KK; Schipper MJ
J Nucl Med; 2021 Aug; 62(8):1118-1125. PubMed ID: 33443063
[TBL] [Abstract][Full Text] [Related]
8. A radiomic- and dosiomic-based machine learning regression model for pretreatment planning in
Plachouris D; Eleftheriadis V; Nanos T; Papathanasiou N; Sarrut D; Papadimitroulas P; Savvidis G; Vergnaud L; Salvadori J; Imperiale A; Visvikis D; Hazle JD; Kagadis GC
Med Phys; 2023 Nov; 50(11):7222-7235. PubMed ID: 37722718
[TBL] [Abstract][Full Text] [Related]
9. Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [
Mansouri Z; Salimi Y; Akhavanallaf A; Shiri I; Teixeira EPA; Hou X; Beauregard JM; Rahmim A; Zaidi H
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1516-1529. PubMed ID: 38267686
[TBL] [Abstract][Full Text] [Related]
10. Toward Single-Time-Point Image-Based Dosimetry of
Brosch-Lenz J; Delker A; Völter F; Unterrainer LM; Kaiser L; Bartenstein P; Ziegler S; Rahmim A; Uribe C; Böning G
J Nucl Med; 2023 May; 64(5):767-774. PubMed ID: 36657980
[TBL] [Abstract][Full Text] [Related]
11. Lu-177-PSMA dosimetry for kidneys and tumors based on SPECT images at two imaging time points.
Chen G; Lu Z; Jiang H; Afshar-Oromieh A; Rominger A; Shi K; Mok GSP
Front Med (Lausanne); 2023; 10():1246881. PubMed ID: 38020081
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a
Zhao W; Esquinas PL; Frezza A; Hou X; Beauregard JM; Celler A
Phys Med Biol; 2019 Aug; 64(17):175006. PubMed ID: 31287093
[No Abstract] [Full Text] [Related]
13. Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies.
Hou X; Brosch J; Uribe C; Desy A; Böning G; Beauregard JM; Celler A; Rahmim A
J Nucl Med; 2021 Jul; 62(7):1006-1011. PubMed ID: 33127625
[TBL] [Abstract][Full Text] [Related]
14. A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After
Dewaraja YK; Mirando DM; Peterson AB; Niedbala J; Millet JD; Mikell JK; Frey KA; Wong KK; Wilderman SJ; Nelson AS
J Nucl Med; 2022 Nov; 63(11):1665-1672. PubMed ID: 35422445
[TBL] [Abstract][Full Text] [Related]
15. Personalized dosimetry of
Carter LM; Ocampo Ramos JC; Kesner AL
Biomed Phys Eng Express; 2021 Aug; 7(5):. PubMed ID: 34271565
[No Abstract] [Full Text] [Related]
16. The Influence of Early Measurements Onto the Estimated Kidney Dose in [(177)Lu][DOTA(0),Tyr(3)]Octreotate Peptide Receptor Radiotherapy of Neuroendocrine Tumors.
Delker A; Ilhan H; Zach C; Brosch J; Gildehaus FJ; Lehner S; Bartenstein P; Böning G
Mol Imaging Biol; 2015 Oct; 17(5):726-34. PubMed ID: 25790773
[TBL] [Abstract][Full Text] [Related]
17. Comparison of voxel S-value methods for personalized voxel-based dosimetry of
Kim KM; Lee MS; Suh MS; Selvam HSMS; Tan TH; Cheon GJ; Kang KW; Lee JS
Med Phys; 2022 Mar; 49(3):1888-1901. PubMed ID: 35014699
[TBL] [Abstract][Full Text] [Related]
18. Bone Marrow Absorbed Doses and Correlations with Hematologic Response During
Hagmarker L; Svensson J; Rydén T; van Essen M; Sundlöv A; Gleisner KS; Gjertsson P; Bernhardt P
J Nucl Med; 2019 Oct; 60(10):1406-1413. PubMed ID: 30902877
[TBL] [Abstract][Full Text] [Related]
19. Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy.
Boursier C; Zaragori T; Bros M; Bordonne M; Melki S; Taillandier L; Blonski M; Roch V; Marie PY; Karcher G; Imbert L; Verger A
Eur Radiol; 2023 Oct; 33(10):7089-7098. PubMed ID: 37148355
[TBL] [Abstract][Full Text] [Related]
20. The relationship between tumour dosimetry, response, and overall survival in patients with unresectable Neuroendocrine Neoplasms (NEN) treated with
Alipour R; Jackson P; Bressel M; Hogg A; Callahan J; Hicks RJ; Kong G
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):2997-3010. PubMed ID: 37184682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]